Next Article in Journal
Effect of Bacteriophage Infection in Combination with Tobramycin on the Emergence of Resistance in Escherichia coli and Pseudomonas aeruginosa Biofilms
Next Article in Special Issue
The Structure of Human Prions: From Biology to Structural Models—Considerations and Pitfalls
Previous Article in Journal
Mutation of the Highly Conserved Ser-40 of the HIV-1 p6 Gag Protein to Phe Causes the Formation of a Hydrophobic Patch, Enhances Membrane Association, and Polyubiquitination of Gag
Previous Article in Special Issue
Prion Protein-Specific Antibodies-Development, Modes of Action and Therapeutics Application
Article Menu

Export Article

Open AccessArticle
Viruses 2014, 6(10), 3766-3777; doi:10.3390/v6103766

Molecular Modeling of Prion Transmission to Humans

1
Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ. Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, 75013 Paris, France
2
Centro de Investigacion en Sanidad Animal, Carretera de Algete a El Casar, 28130 Madrid, Spain
3
LFB Biomédicaments, 91958 Les Ulis, France
4
Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Unité Maladies neurodégénératives, 69394 Lyon, France
5
AP-HP, Hôpital de la Pitié-Salpêtrière, Cellule nationale de référence des MCJ, F-75013 Paris, France
6
AP-HP, Hôpital de la Pitié-Salpêtrière, Neuropathologie, 75013 Paris, France
*
Author to whom correspondence should be addressed.
Received: 24 July 2014 / Revised: 26 September 2014 / Accepted: 30 September 2014 / Published: 2 October 2014
(This article belongs to the Special Issue Recent Developments in the Prion Field)
View Full-Text   |   Download PDF [313 KB, uploaded 12 May 2015]   |  

Abstract

Using different prion strains, such as the variant Creutzfeldt-Jakob disease agent and the atypical bovine spongiform encephalopathy agents, and using transgenic mice expressing human or bovine prion protein, we assessed the reliability of protein misfolding cyclic amplification (PMCA) to model interspecies and genetic barriers to prion transmission. We compared our PMCA results with in vivo transmission data characterized by attack rates, i.e., the percentage of inoculated mice that developed the disease. Using 19 seed/substrate combinations, we observed that a significant PMCA amplification was only obtained when the mouse line used as substrate is susceptible to the corresponding strain. Our results suggest that PMCA provides a useful tool to study genetic barriers to transmission and to study the zoonotic potential of emerging prion strains. View Full-Text
Keywords: Prion; Protein misfolding cyclic amplification; molecular model; interspecies barrier Prion; Protein misfolding cyclic amplification; molecular model; interspecies barrier
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Levavasseur, E.; Privat, N.; Martin, J.-C.E.; Simoneau, S.; Baron, T.; Flan, B.; Torres, J.-M.; Haïk, S. Molecular Modeling of Prion Transmission to Humans. Viruses 2014, 6, 3766-3777.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top